Navigation Links
New study argues for CT colonography as primary colon cancer screening test
Date:4/23/2009

CT colonography allows radiologists to predict, with a high degree of confidence, whether or not a polyp needs to be evaluated through colonoscopy or removed through polypectomy, according to a study performed at the University of Wisconsin School of Medicine and Public Health in Madison, WI.

The study included 479 patients with 739 CT colonography (CTC) detected lesions. "In our study, we found that when a clinically important polyp is found with CT colonography, a corresponding polyp will be identified at colonoscopy greater than 90% of the time," said Steven M. Wise, MD, lead author of the study. Results from the study showed that 677/739 lesions (91.6%) detected on CTC were also found during optical colonoscopy or surgery. "This means that when a radiologist calls a CTC exam positive, the endoscopist can be confident that a treatable polyp is present. The CTC exam can also show the endoscopist where the polyp is located," said Dr. Wise.

"The results of this study add even more strength to the argument that CTC is an effective primary screening test for colon cancer that can be used to select out patients who will need colonoscopy and polypectomy. CTC is a good screening option for those patients who wish to avoid the sedation and higher complication rate associated with colonoscopy," he said.

"The finding that the vast majority of polyps found on CTC do represent true polyps will help better establish CTC as a first line screening test for colon cancer in clinical practice. Hopefully, this will increase the number of people screened for colon cancer and therefore enable early detection and prevention of this deadly disease," said Dr. Wise.


'/>"/>

Contact: Heather Curry
hcurry@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Patients Had Fewer Infection Rates, Fewer Complications at Blue Distinction Centers for Bariatric Surgery(R), According to HealthCore Study
2. Pennsaid(R) Phase 3 study results to be published in leading international PAIN journal
3. Facet Solutions Completes 1 Year Follow-up on U.S. Pilot Study
4. BUSM study finds photographs of UV exposure can impact sunburns in preteens
5. Telesso initiates post-market head-to-head peripheral IV catheter study
6. FDA Grants Ethicon Endo-Surgery Approval of Its IDE Application to Commence Study of Notes Toolbox(TM)
7. New Study Shows Fish Oil Improves Cholesterol Levels in Professional Football Players
8. Transave Completes Enrollment in Arikace(TM) Phase II Bronchiectasis Study
9. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
10. Mexicos health insurance success offers lessons for US reforms, Lancet study suggests
11. Study: Lizards bask for more than warmth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ( ... patients about the safety issues related to dental restorations. According to the American Academy ... to reach $6.4 billion in 2018 with more than 30 million Americans missing all ...
(Date:12/8/2016)... ... 08, 2016 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it had joined the Pharmaceutical Supply Chain Initiative ... to unite pharmaceutical and healthcare companies that share a vision of better, social, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter ... communities in and around the greater Phoenix metropolitan region, is announcing a charity ... The mission of the Homeless Youth Connection is to promote community awareness of ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again ... that it is one of the early adopters completing EU-U.S. Privacy Shield Certification from ... to provide companies on both sides of the Atlantic with a mechanism to comply ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
(Date:12/8/2016)... 2016 A Small Business Innovative Research (SBIR) ... Health (NIH) to Phoenix -based NeuroEM ... The grant will seek to determine an optimal set ... electromagnetic waves to treat Alzheimer,s Disease. The grant will ... possibly treat other neurologic disorders such as Parkinson,s Disease ...
Breaking Medicine Technology: